RNA is projected to rise to $1.56 by 2027, a +78% move from its current price of $0.5742. SN117 is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.535 | $0.5801 | $0.629 | +1.03% |
| Aug 3 | $0.5226 | $0.586 | $0.6571 | +2.06% |
| Aug 4 | $0.5146 | $0.592 | $0.6811 | +3.11% |
| Aug 5 | $0.5087 | $0.5981 | $0.7032 | +4.17% |
| Aug 6 | $0.5042 | $0.6043 | $0.7241 | +5.24% |
| Aug 7 | $0.5007 | $0.6105 | $0.7443 | +6.32% |
| Aug 8 | $0.4979 | $0.6167 | $0.764 | +7.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4979 | $0.6167 | $0.764 | +7.41% |
| Week 2 | $0.4894 | $0.6624 | $0.8967 | +15.37% |
| Week 3 | $0.4911 | $0.7115 | $1.03 | +23.93% |
| Week 4 | $0.498 | $0.7643 | $1.17 | +33.11% |
| Week 5 | $0.5086 | $0.8209 | $1.33 | +42.98% |
| Week 6 | $0.5219 | $0.8818 | $1.49 | +53.57% |
| Week 7 | $0.5375 | $0.9471 | $1.67 | +64.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
RNA is a cryptocurrency that sits in the Artificial Intelligence (AI) category and is part of the Bittensor Ecosystem and Bittensor Subnets. It trades under the SN117 symbol within an AI-driven ecosystem and is presented as a digital asset in this space. RNA has publicly tracked price activity, with a current price of $0.5742 and a market capitalization of $1.34M.
RNA has traded through a wide range historically, reflecting notable volatility. Its all-time high is $4,712.79 and its all-time low is $0.006365, underscoring a broad price movement over time. These extremes illustrate the scale of price fluctuations seen in this asset’s history.
In market terms, RNA is positioned as a niche asset within AI-focused ecosystems and subnetting structures, traded under the SN117 symbol and connected to the broader Bittensor network framework. The information presented here conveys its current standing and its place within the AI and subnetting categories without implying additional specifics beyond what is disclosed.
RNA is currently priced at $0.5742 and has a market cap of $1.34M, ranking 2547.
The forecast landscape shows a multi-year upside path, with a 2026 average of $0.8734 and a 2026 maximum of $2.06, progressing toward a 2050 average of $2.70 and a maximum of $6.22. The 30-day range is $0.5607 to $1.36, and the annualized volatility sits at 200%.
The prognosis includes bullish years in the nearer and longer horizons, with notable annual ROIs such as 78.1% in 2027 and 84.2% in 2028, while a negative year appears in 2029 (-8.7%). The long-run picture shows higher average prices and rising upside potential, culminating in a 2050 maximum that exceeds $6.22.
A major floor 41.3% below — a decisive break under it would weaken the trend.
Support has flipped 17.4% overhead — reclaiming it would be bullish.
The nearest ceiling, 124.0% above — a clean break opens room to run.
A major ceiling 171.1% above — clearing it would confirm fresh momentum.
Key SN117 support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SN117 market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9277 | Sell | $0.9227 | Sell |
| MA 10 | $0.9472 | Sell | $0.9549 | Sell |
| MA 20 | $1.04 | Sell | $0.9799 | Sell |
| MA 50 | $1.01 | Sell | $1.14 | Sell |
| MA 100 | $1.03 | Sell | $18.60 | Sell |
| MA 200 | $0.9621 | Sell | $184.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.70 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -90.19 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -25.92 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.00 | Buy |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 35.65 | Neutral |
| Momentum (10) | -0.32 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 0.92 | Sell |
| ADX (14) | 14.74 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 40.
Moving averages show SMA50 at $1.01 and SMA200 at $0.9622. Current support is at $0.674 and resistance at $1.29, framing a narrow path for near-term movement.
The 30-day price range runs from $0.5607 to $1.36, and the asset exhibits an annualized volatility of 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.6017 | $0.8734 | $2.06 | 0% | Neutral | |
| $1.07 | $1.56 | $2.46 | +78% | Bullish | |
| $1.02 | $1.61 | $2.74 | +84% | Bullish | |
| $0.4708 | $0.7974 | $1.43 | -9% | Neutral | |
| $0.6515 | $1.18 | $2.22 | +35% | Bullish | |
| $0.9324 | $1.79 | $3.52 | +105% | Bullish | |
| $0.7879 | $1.61 | $3.27 | +84% | Bullish | |
| $0.5998 | $1.30 | $2.73 | +49% | Bullish | |
| $0.6016 | $1.34 | $2.88 | +53% | Bullish | |
| $0.9386 | $2.09 | $4.61 | +139% | Bullish | |
| $1.18 | $2.62 | $6.03 | +200% | Bullish | |
| $1.22 | $2.70 | $6.22 | +209% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.9519 | $1.18 | $1.53 | +105.04% |
| September 2026 | $0.9537 | $1.20 | $1.60 | +1.88% |
| October 2026 | $1.14 | $1.46 | $1.98 | +21.52% |
| November 2026 | $1.16 | $1.50 | $2.08 | +3.16% |
| December 2026 | $1.12 | $1.47 | $2.06 | -2.47% |
Click any year to see its month-by-month SN117 forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SN117 to range from $0.6017 to $2.06 through 2026. The $0.8734 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SN117 price prediction for 2027 points to an average of $1.56 (low $1.07, high $2.46) — a potential gain of +78% on today's $0.5742. Momentum favours further upside here.
In 2028, SN117 is projected to trade between $1.02 and $2.74, averaging $1.61 — a potential gain of +84% from today's $0.5742. That is up +3% on the projected 2027 average. Buyers look set to stay in control over this stretch.
RNA's 2029 outlook centres on $0.7974, within a $0.4708 to $1.43 range. That is -50% versus the projected 2028 average. That marks a -9% change versus current levels. Price action looks broadly range-bound.
By 2030, SN117 could reach as high as $2.22, with a base case around $1.18 and support toward $0.6515 — roughly +35% from $0.5742. Buyers look set to stay in control over this stretch.
Expect SN117 to range from $0.9324 to $3.52 through 2031. The $1.79 average target implies a +105% move from current prices. That is up +52% on the projected 2030 average. Momentum favours further upside here.
The SN117 price prediction for 2032 points to an average of $1.61 (low $0.7879, high $3.27) — a potential gain of +84% on today's $0.5742. Buyers look set to stay in control over this stretch.
In 2033, SN117 is projected to trade between $0.5998 and $2.73, averaging $1.30 — a potential gain of +49% from today's $0.5742. That is -19% versus the projected 2032 average. Momentum favours further upside here.
RNA's 2034 outlook centres on $1.34, within a $0.6016 to $2.88 range. That is up +3% on the projected 2033 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SN117 could reach as high as $4.61, with a base case around $2.09 and support toward $0.9386 — roughly +139% from $0.5742. Momentum favours further upside here.
Expect SN117 to range from $1.18 to $6.03 through 2040. The $2.62 average target implies a +200% move from current prices. That is up +26% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SN117 price prediction for 2050 points to an average of $2.70 (low $1.22, high $6.22) — a potential gain of +209% on today's $0.5742. Momentum favours further upside here.
Investing $1,000 in SN117 today (≈ 1,741.626261 SN117) could be worth
$4,706.21
+$3,706.21 (+371%) by 2050 · US Dollar
Based on the average projected SN117 price of $2.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SN117would be worth at today's price.
$1,000 invested in SN117 on Jun 17, 2025 (≈ 0.288963 SN117) would be worth
$0.17
-$999.83 (-100.0%) today · 0.00× · US Dollar
Based on a SN117 entry price of $3,460.65 vs. today's $0.574176.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.92462 | $620.99 | -37.9% |
| 1 month ago | $1.04 | $549.49 | -45.1% |
| 3 months ago | $1.12 | $513.41 | -48.7% |
| 6 months ago | $0.784832 | $731.59 | -26.8% |
| 1 year ago | $3,460.65 | $0.17 | -100.0% |
| All time (1.1y) ago | $1,706.47 | $0.34 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SN117 forecast.
Our base-case forecast reaches $1.10 around 2027.
Implied market cap at $1.10: $2.56M
The year-by-year forecast provides a clear min/avg/max progression. For 2026, the min is $0.6017, the avg is $0.8734, and the max is $2.06. In 2027, the min is $1.07, the avg is $1.56, and the max is $2.46.
Key longer-horizon milestones include 2030 with an avg $1.18 and ROI 34.9% (sentiment BULLISH), 2031 with avg $1.79 and ROI 105.5% (BULLISH), 2035 with avg $2.09 and ROI 138.8% (BULLISH), 2040 with avg $2.62 and ROI 200.4% (BULLISH), and 2050 with avg $2.70 and ROI 209.4% (BULLISH).
Across the forecast, sentiment is BULLISH in most years, with a single negative year in 2029 showing ROI -8.7%. The long-run picture suggests upside potential, but it remains subject to the inherent uncertainty and volatility associated with these forecasts.
Tap a question to reveal the answer.
Avg $1.18; min $0.6515; max $2.22; ROI 34.9%; sentiment BULLISH.
The year-by-year forecast includes several bullish years with positive ROIs (e.g., 2027 ROI 78.1%, 2028 ROI 84.2%, 2031 ROI 105.5%, 2040 ROI 200.4%, 2050 ROI 209.4%), but there is a negative year in 2029 (-8.7%). Returns are not guaranteed and depend on market conditions.
The modeled max values show $6.22 by 2050 and $6.03 by 2040; 2035 max $4.61. Since $5 lies above the 2035 maximum but below the 2040 maximum, the forecast implies that a $5 level could occur within the modeled path, potentially by 2040.
Current price $0.5742; market cap $1.34M.
Sentiment NEUTRAL; RSI14 40; SMA50 $1.01; SMA200 $0.9622; support $0.674; resistance $1.29; 30-day range $0.5607–$1.36; annualized volatility 200%.
RNA Community Discussion
0Share your RNA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.